{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:58:28Z","timestamp":1791223108846,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["DEC-2011\/03\/N\/NZ5\/00248"],"award-info":[{"award-number":["DEC-2011\/03\/N\/NZ5\/00248"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Foundation for Polish Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.psychres.2016.01.077","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T07:57:26Z","timestamp":1455091046000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism"],"prefix":"10.1016","volume":"238","author":[{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"\u0141aczma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Kinga","family":"S\u0142oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Szmida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Piotrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Loska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"\u015al\u0119zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kiejna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Frydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2016.01.077_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pnpbp.2013.04.020","article-title":"Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study","volume":"45","author":"Albayrak","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00406-012-0302-2","article-title":"Homocysteine and cognition in first-episode psychosis patients","volume":"262","author":"Ayesa-Arriola","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2016.01.077_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psychres.2010.04.008","article-title":"Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics","volume":"179","author":"Bouaziz","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.psychres.2013.08.056","article-title":"Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia","volume":"210","author":"Chen","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.20830","article-title":"The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects","volume":"30","author":"Christensen","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.psychres.2016.01.077_bib6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study","volume":"71","author":"Correll","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates An association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2007.09.030","article-title":"Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C\/T and 1298A\/C variants","volume":"98","author":"Ellingrod","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JCP.0b013e3182485888","article-title":"Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics","volume":"32","author":"Ellingrod","year":"2012","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.01.077_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/YCO.0b013e3283568537","article-title":"Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics","volume":"25","author":"Ferentinos","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archgenpsychiatry.2011.2","article-title":"Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis","volume":"68","author":"Foley","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.psychres.2016.01.077_bib13","article-title":"Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","author":"Garcia-Bueno","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.01.077_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpsychires.2009.10.011","article-title":"Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia","volume":"44","author":"Garcia-Miss Mdel","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0021-9150(00)00739-5","article-title":"The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations","volume":"157","author":"Gaughan","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.psychres.2016.01.077_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwj347","article-title":"Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review","volume":"165","author":"Gilbody","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.psychres.2016.01.077_bib17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1176\/appi.ajp.161.9.1705","article-title":"Folate, homocysteine, and negative symptoms in schizophrenia","volume":"161","author":"Goff","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.schres.2007.12.476","article-title":"Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects","volume":"101","author":"Graham","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2011.01.031","article-title":"At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia","volume":"70","author":"Hansen","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11892-010-0112-8","article-title":"Metabolic syndrome associated with schizophrenia and atypical antipsychotics","volume":"10","author":"Hasnain","year":"2010","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.psychres.2016.01.077_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.12.006","article-title":"Folate supplementation in schizophrenia: a possible role for MTHFR genotype","volume":"127","author":"Hill","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00702-014-1261-8","article-title":"Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis","volume":"122","author":"Hu","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psychres.2016.01.077_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2009.07.008","article-title":"Genetic risk factors for type 2 diabetes with pharmacologic intervention in African\u2013American patients with schizophrenia or schizoaffective disorder","volume":"114","author":"Irvin","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.schres.2015.08.019","article-title":"Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups","volume":"168","author":"Joseph","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpsychires.2014.03.012","article-title":"Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances","volume":"54","author":"Kao","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.01.077_bib28","doi-asserted-by":"crossref","first-page":"e24597","DOI":"10.1371\/journal.pone.0024597","article-title":"Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder","volume":"6","author":"Laursen","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2016.01.077_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopsych.2005.10.009","article-title":"Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia","volume":"60","author":"Levine","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib30","doi-asserted-by":"crossref","first-page":"e67133","DOI":"10.1371\/journal.pone.0067133","article-title":"Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries","volume":"8","author":"Laursen","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.psychres.2016.01.077_bib31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymgme.2008.03.013","article-title":"Human betaine-homocysteine methyltransferase (BHMT) and BHMT2: common gene sequence variation and functional characterization","volume":"94","author":"Li","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.psychres.2016.01.077_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/cr.2009.33","article-title":"A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis","volume":"19","author":"Li","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/YPG.0b013e32833a2234","article-title":"Genetic association of the AKT1 gene with schizophrenia in a British population","volume":"20","author":"Mathur","year":"2010","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.psychres.2016.01.077_bib34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00228-014-1762-2","article-title":"Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients","volume":"70","author":"Misiak","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2016.01.077_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2217\/epi.13.22","article-title":"The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation","volume":"5","author":"Misiak","year":"2013","journal-title":"Epigenomics"},{"key":"10.1016\/j.psychres.2016.01.077_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11011-014-9534-3","article-title":"Elevated homocysteine level in first-episode schizophrenia patients\u2014the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse","volume":"29","author":"Misiak","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.psychres.2016.01.077_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.01.077_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders-focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.psychres.2016.01.077_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.mp.4001746","article-title":"Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis","volume":"11","author":"Muntjewerff","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of Blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.01.077_bib41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.bbi.2010.12.006","article-title":"Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?","volume":"25","author":"Peerbooms","year":"2011","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.psychres.2016.01.077_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib43","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia","volume":"32","author":"Petronijevic","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.schres.2010.12.008","article-title":"Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?","volume":"127","author":"Phutane","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/schbul\/sbr150","article-title":"Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia","volume":"39","author":"Roffman","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.01.077_bib46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2013.900","article-title":"Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia","volume":"70","author":"Roffman","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib48","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ajmg.b.31057","article-title":"Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia","volume":"153B","author":"Scholz","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.psychres.2016.01.077_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib50","first-page":"51","article-title":"Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia","volume":"11","author":"Sicras-Mainar","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2016.01.077_bib51","first-page":"1","article-title":"Methylenetetrahydrofolate reductase (MTHFR) 677C\/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia","author":"Srisawat","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.01.077_bib52","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2147\/NDT.S74760","article-title":"Dietary patterns and schizophrenia: a comparison with healthy controls","volume":"11","author":"Tsuruga","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2016.01.077_bib53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.comppsych.2014.10.007","article-title":"Negative symptoms are associated with lower autonomous motivation towards physical activity in people with schizophrenia","volume":"56","author":"Vancampfort","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0447.2011.01814.x","article-title":"A systematic review of correlates of physical activity in patients with schizophrenia","volume":"125","author":"Vancampfort","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2016.01.077_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2011.03.018","article-title":"Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia","volume":"129","author":"Vancampfort","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/wps.20069","article-title":"A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls","volume":"12","author":"Vancampfort","year":"2013","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib57","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis","volume":"70","author":"Verma","year":"2009","journal-title":"J.\u00a0Clin. psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2013.07.051","article-title":"The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls","volume":"150","author":"Wu","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.01.077_bib59","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4088\/JCP.v68n0906","article-title":"Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population","volume":"68","author":"Xu","year":"2007","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2016.01.077_bib60","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.psyneuen.2015.09.005","article-title":"Glucose disturbances in first-episode drug-naive schizophrenia: relationship to psychopathology","volume":"62","author":"Zhang","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2016.01.077_bib61","first-page":"1","article-title":"Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus","author":"Zhou","year":"2015","journal-title":"Ren. Fail."},{"key":"10.1016\/j.psychres.2016.01.077_bib62","doi-asserted-by":"crossref","first-page":"e102443","DOI":"10.1371\/journal.pone.0102443","article-title":"Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case\u2013control studies","volume":"9","author":"Zhu","year":"2014","journal-title":"PloS One"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115304194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115304194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:22:08Z","timestamp":1718353328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178115304194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":62,"alternative-id":["S0165178115304194"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.01.077","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.01.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}